We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$12.3B
AUM Growth
+$227M
Cap. Flow
-$346M
Cap. Flow %
-2.81%
Top 10 Hldgs %
24.75%
Holding
2,377
New
669
Increased
496
Reduced
623
Closed
582

Top Sells

Rank Stock Value
1
NI icon
NiSource
NI
+$77.7M
2
LIN icon
Linde
LIN
+$71M
3
DTE icon
DTE Energy
DTE
+$57.1M
4
FCX icon
Freeport-McMoran
FCX
+$51.7M
5
FDX icon
FedEx
FDX
+$44.9M

Sector Composition

Rank Sector Weight
1 Industrials 11.08%
2 Technology 9.69%
3 Healthcare 9.12%
4 Real Estate 6.85%
5 Utilities 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BW icon
1751
Babcock & Wilcox
BW
$1.39B
$100K ﹤0.01%
+16,950
New +$99.4K
BLDP
1752
Ballard Power Systems
BLDP
$790M
$99K ﹤0.01%
+22,620
New +$103K
IWM icon
1753
iShares Russell 2000 ETF
IWM
$83B
$99K ﹤0.01%
+529
New +$94.3K
OSCR icon
1754
Oscar Health
OSCR
$8.61B
$98K ﹤0.01%
+12,097
New +$89.2K
HNRG icon
1755
Hallador Energy
HNRG
$696M
$94K ﹤0.01%
+10,957
New +$93.4K
ANGI icon
1756
Angi Inc
ANGI
$196M
$90K ﹤0.01%
+2,726
New +$76.3K
FEAM icon
1757
5E Advanced Materials
FEAM
$62.3M
$90K ﹤0.01%
+1,187
New +$113K
KEP icon
1758
Korea Electric Power
KEP
$16B
$88K ﹤0.01%
+11,339
New +$81.5K
KLRS
1759
Kalaris Therapeutics
KLRS
$96.8M
$88K ﹤0.01%
+1,125
New +$107K
CMAX
1760
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$88K ﹤0.01%
+947
New +$83.4K
TG icon
1761
Tredegar Corp
TG
$310M
$86K ﹤0.01%
+12,961
New +$103K
HOUS
1762
DELISTED
Anywhere Real Estate
HOUS
$75K ﹤0.01%
+11,269
New +$67.6K
BBAI icon
1763
BigBear.ai
BBAI
$1.57B
$73K ﹤0.01%
+30,944
New +$78.4K
AMPS
1764
DELISTED
Altus Power
AMPS
$71K ﹤0.01%
13,196
-75,202
-85% -$371K
ZG icon
1765
Zillow
ZG
$7.63B
$70K ﹤0.01%
+1,424
New +$64.2K
LOGC
1766
DELISTED
ContextLogic
LOGC
$69K ﹤0.01%
+10,562
New +$83.7K
VUZI icon
1767
Vuzix
VUZI
$224M
$66K ﹤0.01%
+13,017
New +$57.6K
LTCH
1768
DELISTED
Latch, Inc. Common Stock
LTCH
$66K ﹤0.01%
+47,176
New +$44.1K
SMMT icon
1769
Summit Therapeutics
SMMT
$11.1B
$65K ﹤0.01%
+25,775
New +$47K
MGNX icon
1770
MacroGenics
MGNX
$257M
$59K ﹤0.01%
+11,081
New +$68.4K
SPIR icon
1771
Spire Global
SPIR
$555M
$56K ﹤0.01%
+13,561
New +$72.2K
NXTC icon
1772
NextCure
NXTC
$26.7M
$55K ﹤0.01%
2,556
-68
-3% -$1.34K
GOEV
1773
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$55K ﹤0.01%
+249
New +$71K
DNA icon
1774
Ginkgo Bioworks
DNA
$521M
$52K ﹤0.01%
703
-20,421
-97% -$1.21M
MAPS
1775
DELISTED
WM TECHNOLOGY INC A
MAPS
$52K ﹤0.01%
+61,627
New +$50.4K

Similar funds

ExodusPoint Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, ExodusPoint Capital Management held 2,377 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

ExodusPoint Capital Management's Q2 2023 filing shows 669 new, 496 increased, 623 reduced and 582 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M. The largest sale was NiSource, an estimated $77.7M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • ExodusPoint Capital Management's largest Q2 2023 buy was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M.
  • ExodusPoint Capital Management added most to Global Payments in Q2 2023, an estimated $308M increase.
  • ExodusPoint Capital Management's biggest Q2 2023 reduction was NiSource, cutting an estimated $77.7M.
  • ExodusPoint Capital Management fully exited L3Harris in Q2 2023, selling an estimated $44.7M.
  • ExodusPoint Capital Management's ten largest holdings make up 25% of its $12.3B portfolio in Q2 2023.
  • ExodusPoint Capital Management opened 669 new positions and closed 582 in Q2 2023.
  • ExodusPoint Capital Management's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.